Critical COPD respiratory illness is linked to increased transcriptomic activity of neutrophil proteases genes

BMC Research Notes

Volumn 5, Issue , 2012, Pages

  Almansa, Raquel ^a   Socias, Lorenzo ^b   Sanchez Garcia, Monica ^a   Martín Loeches, Ignacio ^c   Del Olmo, Milagros ^a   Andaluz Ojeda, David ^a   Bobillo, Felipe ^a   Rico, Lucia ^a   Herrero, Agueda ^a   Roig, Vicente ^a   San Jose, C Alicia ^a   Rosich, Sara ^d   Barbado, Julia ^a   Disdier, Carlos ^a   De Lejarazu, Raúl Ortiz ^a   Gallegos, Maria C ^b   Fernandez, Victoria ^b   Bermejo Martin, Jesus F ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^b HOSPITAL SON LLÀTZER   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

Author keywords

COPD; Critical; Expression; Gene; Microarray; Neutrophil; Proteases

Indexed keywords

BACTERIA (MICROORGANISMS);

ANTIMICROBIAL CATIONIC PEPTIDE; MESSENGER RNA; PEPTIDE HYDROLASE; PEROXIDASE; TRANSCRIPTOME;

AGED; ARTICLE; BLOOD; CHRONIC OBSTRUCTIVE LUNG DISEASE; CRITICAL ILLNESS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC MARKER; GENETICS; HUMAN; INTENSIVE CARE UNIT; MALE; METABOLISM; MIDDLE AGED; NEUTROPHIL; PATHOLOGY; SEVERITY OF ILLNESS INDEX;

AGED; ANTIMICROBIAL CATIONIC PEPTIDES; CRITICAL ILLNESS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC MARKERS; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; NEUTROPHILS; PEPTIDE HYDROLASES; PEROXIDASE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; TRANSCRIPTOME;

EID: 84864446365     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-5-401     Document Type: Article

References (19)

1. Exacerbations of chronic obstructive pulmonary disease. Celli BR, Barnes PJ, Eur Respir J 2007 29 6 1224 1238 10.1183/09031936.00109906 17540785 (Pubitemid 46895385)
2. Severity and Outcomes of hospitalised community-acquired pneumonia in COPD patients. Liapikou A, Polverino E, Ewig S, Cilloniz C, Marcos MA, Mensa J, Bello S, Martin-Loeches I, Menendez R, Torres A, Eur Respir J 2012 39 4 855 61 10.1183/09031936.00067111 21920895
3. Assessing the human immune system through blood transcriptomics. Chaussabel D, Pascual V, Banchereau J, BMC Biol 8 84
4. Peripheral blood gene expression profiles in COPD subjects. Bhattacharya S, Tyagi S, Srisuma S, Demeo DL, Shapiro SD, Bueno R, Silverman EK, Reilly JJ, Mariani TJ, J Clin Bioinform 2011 1 1 12 10.1186/2043-9113-1-12
5. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM, Musher DM, Niederman MS, et al. Clin Infect Dis 2007 44 Suppl 2 27 72 17278083
6. Manual of Clinical Microbiology Washington, DC: American Society for Microbiology, Versalovic JCK, Funke G, Jorgensen JH, Landry ML, Warnock DW, 10 2011
7. Structural characterization of mouse neutrophil serine proteases and identification of their substrate specificities: relevance to mouse models of human inflammatory diseases. Kalupov T, Brillard-Bourdet M, Dade S, Serrano H, Wartelle J, Guyot N, Juliano L, Moreau T, Belaaouaj A, Gauthier F, J Biol Chem 2009 284 49 34084 34091 10.1074/jbc.M109.042903 19833730
8. Neutrophil serine proteinases and defensins in chronic obstructive pulmonary disease: effects on pulmonary epithelium. Hiemstra PS, van Wetering S, Stolk J, Eur Respir J 1998 12 5 1200 1208 10.1183/09031936.98.12051200 9864022 (Pubitemid 28545637)
9. The role of proteinases in the pathogenesis of chronic bronchitis. Stockley RA, Am J Respir Crit Care Med 1994 150 6 Pt 2 109 113 7952644
10. Prevention of leucocyte elastase-induced emphysema in mice by heparin fragments. Lafuma C, Frisdal E, Harf A, Robert L, Hornebeck W, Eur Respir J 1991 4 8 1004 1009 1783073
11. Genetic risk factors for chronic obstructive pulmonary disease. Sandford AJ, Weir TD, Pare PD, Eur Respir J 1997 10 6 1380 1391 10.1183/09031936.97. 10061380 9192947 (Pubitemid 27278264)
12. Matrix metalloproteinase-12 and cathepsin D expression in pulmonary macrophages and dendritic cells of cigarette smoke-exposed mice. Bracke K, Cataldo D, Maes T, Gueders M, Noel A, Foidart JM, Brusselle G, Pauwels RA, Int Arch Allergy Immunol 2005 138 2 169 179 10.1159/000088439 16192742 (Pubitemid 41540674)
13. The contribution of neutrophil-derived myeloperoxidase in the early phase of fulminant acute respiratory distress syndrome induced by influenza virus infection. Sugamata R, Dobashi H, Nagao T, Yamamoto KI, Nakajima N, Sato Y, Aratani Y, Oshima M, Sata T, Kobayashi K, et al. Microbiol Immunol
14. Cellular and molecular mechanisms in chronic obstructive pulmonary disease: an overview. Di Stefano A, Caramori G, Ricciardolo FL, Capelli A, Adcock IM, Donner CF, Clin Exp Allergy 2004 34 8 1156 1167 10.1111/j.1365-2222. 2004.02030.x 15298554 (Pubitemid 39093053)
15. Late Intervention with a Myeloperoxidase Inhibitor Stops Progression of Experimental COPD. Churg A, Marshall CV, Sin DD, Bolton S, Zhou S, Thain K, Cadogan EB, Maltby J, Soars MG, Mallinder PR, et al. Am J Respir Crit Care Med 2012 185 1 34 43 10.1164/rccm.201103-0468OC 21997333
16. Contribution of alpha- and beta-defensins to lung function decline and infection in smokers: an association study. Wallace AM, He JQ, Burkett KM, Ruan J, Connett JE, Anthonisen NR, Pare PD, Sandford AJ, Respir Res 2006 7 76 10.1186/1465-9921-7-76 16700921 (Pubitemid 44131692)
17. Complement activation by myeloperoxidase products released from stimulated human polymorphonuclear leukocytes. Vogt W, Immunobiology 1996 195 3 334 346 10.1016/S0171-2985(96)80050-7 8877407 (Pubitemid 26275778)
18. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease. Valipour A, Schreder M, Wolzt M, Saliba S, Kapiotis S, Eickhoff P, Burghuber OC, Clin Sci (Lond) 2008 115 7 225 232 10.1042/CS20070382
19. Airway angiogenesis in stable and exacerbated chronic obstructive pulmonary disease. Kristan SS, Marc MM, Kern I, Flezar M, Suskovic S, Kosnik M, Korosec P, Scand J Immunol 2012 75 1 109 114 10.1111/j.1365-3083.2011.02623.x 21916917